HawkInsight

  • Contact Us
  • App
  • English

罗氏制药公告称,临床试验结果表明,通过更加缓慢地向受试病患给药更高剂量的减肥药,试验性减肥药的副作用更加温和。罗氏ADR下跌3.6%,诺和诺德ADR涨3%刷新日高,礼来涨1.6%。

罗氏制药公告称,临床试验结果表明,通过更加缓慢地向受试病患给药更高剂量的减肥药,试验性减肥药的副作用更加温和。罗氏ADR下跌3.6%,诺和诺德ADR涨3%刷新日高,礼来涨1.6%。

Disclaimer: The views in this article are from the original author and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.

NewFlashHawk Insight
More